Cosmax Nbt, Inc. (KOSDAQ:222040)
6,350.00
-380.00 (-5.65%)
At close: Oct 2, 2026
Cosmax Nbt Market Cap
Cosmax Nbt has a market cap or net worth of 130.52 billion as of October 2, 2026. Its market cap has increased by 68.88% in one year.
Market Cap
130.52B
Enterprise Value
239.16B
Revenue
335.18B
Ranking
n/a
PE Ratio
4.68
Stock Price
6,350.00
ChartMarket Cap Chart
Since December 16, 2015, Cosmax Nbt's market cap has decreased from 299.11B to 130.52B, a decrease of -56.36%. That is a compound annual growth rate of -7.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 130.52B | 81.43% |
| Dec 30, 2025 | 71.94B | 13.45% |
| Dec 30, 2024 | 63.41B | -51.95% |
| Dec 28, 2023 | 131.96B | 49.12% |
| Dec 29, 2022 | 88.49B | -25.78% |
| Dec 30, 2021 | 119.23B | -32.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GC WellBeing | 200.75B |
| CellBion | 184.67B |
| NOVAREX | 175.98B |
| Vivozon Pharmaceutical | 171.17B |
| HYUNDAI BIOLAND | 162.00B |
| Kyung Dong Pharmaceutical | 146.79B |
| PHARMARESEARCH BIO | 119.99B |
| Ahn-Gook Pharmaceutical | 113.54B |